Stocks were indicated to be weak on Monday, with some of the blame placed on sanctions and international pressure on Russia. Many investors are still looking for upside and sectors in which to hide. 24/7 Wall St. reviews dozens of analyst reports each morning to find new research-driven ideas for our readers. Some of these analyst calls cover stocks to buy, and some of them cover stocks to sell or to avoid.

These are this Monday’s top analyst upgrades, downgrades and initiations from Wall Street firms.

Apple Inc. (NASDAQ: AAPL) was raised to Outperform from Market Perform at JMP Securities, but the price target was up at $135. Over the weekend we highlighted how analysts and Wall Street investors are valuing Apple ahead of earnings, and it is far less robust than $135.

ARM Holdings PLC (NASDAQ: ARMH) was maintained as Neutral but saw its price target cut in overseas coverage at Citigroup. When you translate the U.K. to U.S. prices, it implies upside of just under 3% now, rather than almost 15% upside previously.

ALSO READ: 12 Analyst Stocks Under $10 With Massive Upside Potential

DaVita HealthCare Partners Inc. (NYSE: DVA) was downgraded to Market Perform from Outperform at Raymond James.

Fifth Third Bancorp (NASDAQ: FITB) was raised to Outperform from Neutral with a $23 price target (versus a $20.45 close) at Baird.

General Electric Co. (NYSE: GE) was maintained as Buy with a $29 price target at Bank of America Merrill Lynch, with the firm saying that the fundamentals are better than sentiment would suggest. Still, the firm cut its 2014 earnings from $1.69 to $1.67 per share as higher industrial profit growth is more than offset by higher corporate expense forecast.

GoPro Inc. (NASDAQ: GPRO) has seen its quiet period come to an end. What is interesting is that the full coverage was very mixed in ratings, yet the stock was indicated up 2% early Monday.

Gol Linhas Aéreas Inteligentes S.A. (NYSE: GOL) was raised to Buy from Neutral with an $8 price target (versus a $5.80 close) at Merrill Lynch.

Itron Inc. (NASDAQ: ITRI) was downgraded to Underperform from Buy and the price target was cut to $39 from $40 at Merrill Lynch. The firm sees risks to growth increasing due to meter roll-out delays and new competitive threats.

ALSO READ: Analysts Change Views Handily on AMD Turnaround

Materialise N.V. (NASDAQ: MTLS) was started as Outperform and assigned a $15 price target (versus a $12.46 close) at Credit Suisse. The firm said the company is a software play with exposure to key 3D growth engines for medical and increasing production use.

Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) was started with a Buy rating and a target price of $375 (versus a $305.92 close) at Argus. The firm based coverage on Eylea growth in wet age-related macular degeneration, additional Eylea uses, valuable collaboration agreements with Sanofi and Bayer, and a strong pipeline for drugs covering rheumatoid arthritis and cholesterol reduction.

TCP International Holdings Ltd. (NYSE: TCPI) was started as Buy and was given a $15 price target (versus a $10.85 close) at Canaccord Genuity. Cowen started coverage as Outperform and with an $18 price target.

ALSO READ: Top Biotech Earnings on Deck This Week

Other analyst calls worth noting on Monday were as follows:

• America Movil SAB de C.V. (NYSE: AMX) was downgraded to Sell from Hold by Morgan Stanley.
• AU Optronics Corp. (NYSE: AUO) was downgraded from Neutral to Sell by UBS.
• Avianca Holdings S.A. (NYSE: AVH) was downgraded to Neutral from Buy at Merrill Lynch.
• Baker Hughes Inc. (NYSE: BHI) was raised to Buy at Guggenheim.
• ITC Holdings Corp. (NYSE: ITC) was raised to Buy with a price target of $42 (versus a $35.87 close) at Argus.
• LATAM Airlines Group S.A. (NYSE: LFL) was downgraded to Neutral from Buy at Merrill Lynch.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.